NO883520D0 - Fremgangsmaate for fremstilling av et injeksjonspreparat. - Google Patents

Fremgangsmaate for fremstilling av et injeksjonspreparat.

Info

Publication number
NO883520D0
NO883520D0 NO883520A NO883520A NO883520D0 NO 883520 D0 NO883520 D0 NO 883520D0 NO 883520 A NO883520 A NO 883520A NO 883520 A NO883520 A NO 883520A NO 883520 D0 NO883520 D0 NO 883520D0
Authority
NO
Norway
Prior art keywords
preparation
procedure
injection
solubility
salt
Prior art date
Application number
NO883520A
Other languages
English (en)
Other versions
NO178325B (no
NO178325C (no
NO883520L (no
Inventor
Marahiro Kawahara
Yuichiro Hayashi
Naoki Asakawa
Sumio Watanabe
Yasuo Miyake
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16406817&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO883520(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO883520D0 publication Critical patent/NO883520D0/no
Publication of NO883520L publication Critical patent/NO883520L/no
Publication of NO178325B publication Critical patent/NO178325B/no
Publication of NO178325C publication Critical patent/NO178325C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO883520A 1987-08-10 1988-08-08 Fremgangsmåte for fremstilling av et t-PA injeksjonspreparat NO178325C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62199381A JP2708749B2 (ja) 1987-08-10 1987-08-10 修飾型ｔＰＡ含有注射用組成物

Publications (4)

Publication Number Publication Date
NO883520D0 true NO883520D0 (no) 1988-08-08
NO883520L NO883520L (no) 1989-02-13
NO178325B NO178325B (no) 1995-11-27
NO178325C NO178325C (no) 1996-03-06

Family

ID=16406817

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883520A NO178325C (no) 1987-08-10 1988-08-08 Fremgangsmåte for fremstilling av et t-PA injeksjonspreparat

Country Status (11)

Country Link
US (1) US5425943A (no)
EP (1) EP0303251B1 (no)
JP (1) JP2708749B2 (no)
KR (1) KR910009366B1 (no)
AT (1) ATE84220T1 (no)
CA (1) CA1338699C (no)
DE (1) DE3877277T2 (no)
DK (1) DK443988A (no)
ES (1) ES2052651T3 (no)
GR (1) GR3006748T3 (no)
NO (1) NO178325C (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453363A (en) * 1985-10-23 1995-09-26 Boehringer Mannheim Gmbh Process for the activation of t-PA or Ing after genetic expression in prokaryotes
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
JP2520975B2 (ja) * 1989-09-21 1996-07-31 三井東圧化学株式会社 組織プラスミノ―ゲンアクチベ―タ―若しくはその誘導体を含有する血栓溶解剤
DE3939346A1 (de) * 1989-11-29 1991-06-06 Behringwerke Ag Arzneimitel zur subkutanen oder intramuskulaeren applikation enthaltend polypeptide
US6372716B1 (en) * 1994-04-26 2002-04-16 Genetics Institute, Inc. Formulations for factor IX
US5770700A (en) * 1996-01-25 1998-06-23 Genetics Institute, Inc. Liquid factor IX formulations
TWI240627B (en) * 1996-04-26 2005-10-01 Chugai Pharmaceutical Co Ltd Erythropoietin solution preparation
EP0827751B1 (en) * 1996-09-06 2003-02-26 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Medicinal composition containing tissue plasminogen activator and nicotinamide

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54147916A (en) * 1978-05-12 1979-11-19 Sumitomo Chem Co Ltd Preparation of urokinase injection
WO1984001786A1 (en) * 1982-10-28 1984-05-10 Beecham Group Plc Enzyme derivatives and their use in the treatment of thrombosis
GB8334498D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Compounds
JPS60184026A (ja) * 1984-03-01 1985-09-19 Asahi Chem Ind Co Ltd 組織プラスミノ−ゲン・アクチベ−タ−の溶解補助方法
EP0156169B1 (en) * 1984-02-29 1991-12-18 Asahi Kasei Kogyo Kabushiki Kaisha An aqueous solution of a tissue plasminogen activator dissolved therein at an increased concentration and a method
JPS60181028A (ja) * 1984-02-29 1985-09-14 Asahi Chem Ind Co Ltd 組織プラスミノ−ゲン・アクチベ−タ−の溶解補助法
GB8503358D0 (en) * 1985-02-09 1985-03-13 Beecham Group Plc Compounds
GB8508717D0 (en) * 1985-04-03 1985-05-09 Beecham Group Plc Composition
DE3682104D1 (de) * 1985-04-22 1991-11-28 Genentech Inc Plasminogenaktivator-mutante des menschlichen gewebes, verfahren und zwischenprodukte dafuer und diese mutante verwendende zusammensetzungen.
US4916071A (en) * 1985-08-14 1990-04-10 American Home Products Corporation Poly-kringle plasminogen activator
NZ217331A (en) * 1985-08-26 1989-05-29 Lilly Co Eli Tissue plasminogen activator derivatives and genetically engineered product
US4960702A (en) * 1985-09-06 1990-10-02 Codon Methods for recovery of tissue plasminogen activator
JPH0811066B2 (ja) * 1985-09-30 1996-02-07 インテグレーテッド・ジエネティックス・インコーポレーテッド 組換えｄｎａが生産するヒト子宮プラスミノ−ゲンアクチベ−タ−
JPH0672105B2 (ja) * 1985-10-02 1994-09-14 持田製薬株式会社 血栓溶解剤及びその製法
JPS62120321A (ja) * 1985-11-20 1987-06-01 Eisai Co Ltd ｔＰＡ含有医薬組成物
US4777043A (en) 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
EP0227462B1 (en) * 1985-12-23 1992-04-01 Chiron Corporation Novel peptide plasminogen activators
US4935237A (en) * 1988-03-21 1990-06-19 Genentech, Inc. Processes for the preparation of t-PA mutants
US4898826A (en) * 1987-12-10 1990-02-06 Invitron Corporation Method to solubilize tissue plasminogen activator

Also Published As

Publication number Publication date
ATE84220T1 (de) 1993-01-15
DE3877277D1 (de) 1993-02-18
EP0303251A2 (en) 1989-02-15
NO178325B (no) 1995-11-27
NO178325C (no) 1996-03-06
GR3006748T3 (no) 1993-06-30
EP0303251B1 (en) 1993-01-07
JPS6442442A (en) 1989-02-14
ES2052651T3 (es) 1994-07-16
JP2708749B2 (ja) 1998-02-04
US5425943A (en) 1995-06-20
KR910009366B1 (ko) 1991-11-14
KR890003404A (ko) 1989-04-14
EP0303251A3 (en) 1990-01-31
NO883520L (no) 1989-02-13
DK443988A (da) 1989-02-11
DK443988D0 (da) 1988-08-09
DE3877277T2 (de) 1993-06-03
CA1338699C (en) 1996-11-12

Similar Documents

Publication Publication Date Title
NO905608L (no) Fremgangsmaate for fremstilling av a-nor-steroid-3-karboksylsyrederivater.
NO882732D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
SE8603582D0 (sv) Komposition innehallande l-dopa
BG92179A (bg) Метод за получаване на 7-заместена-хепт-6-еноена и -хептаноена киселина и техни производни и междинни съединения
NO883520D0 (no) Fremgangsmaate for fremstilling av et injeksjonspreparat.
PT86233A (fr) Procede de preparation d:une variant de l:hirudine
NO863373D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyre derivater.
ATE65401T1 (de) Stabile, injizierbare loesungen von salzen von vincristin.
BG88028A (bg) Амиди на циклометилен-1,2-дикарбоксилни киселини с терапевтична активност,методи за получаването им и фармацевтични състави, които ги съдържат
ATE92315T1 (de) Aminosaeurederivate enthaltende antikonvulsive zusammensetzungen und verwendung dieser aminosaeurederivate.
NO177484C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat i form av myke kapsler
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
OA07270A (fr) Dérivés N-(vinblastinoyl-23) d'acide aminés, leur préparation et leur application thérapeutique.
PT87628A (pt) Process for the preparation of a fungicidal composition cintaining (2-cyano-2-oxyminoacetyl)-aminoacids derivatives
EP0142597A3 (en) Curative composition for buerger's disease
ATE10845T1 (de) Verfahren zur herstellung von n-(4-(((2,4-diamino-6-pteridinyl)methyl)methyla ino)benzoyl)- glutaminsaeure.
ES512769A0 (es) "procedimiento para la preparacion de esteres 2-metoxifenilicos de aminoacidos n-substituidos".
KR900012610A (ko) 치환 헥센산유도체의 주사용 제제
NO168470C (no) Fremgangsmaate for fremstilling av 5-hydroksydiprafenon ogsyreaddisjonssalter derav.
SE8505801L (sv) I,4-dihydropyridin-derivat, deras framstellning och farmaceutiska beredningar innehallande dessa
SE8303400D0 (sv) Azo-bis-salicylsyra och salt derav samt deras farmaceutiska beredning och anvendning
DK163661C (da) 2,5-pyrrolidindionderivater og farmaceutisk acceptable syreadditionssalte deraf
NO880034D0 (no) Fremgangsmaate for fremstilling av krystallinsk aminobeskyttet beta-benzyl-l-aspartinsyre.
YU47871B (sh) Derivati aminokiselina
DE69002027D1 (de) (3-diethylaminopropyl)-1-amino-5-methyldipyrido(4,3-b)(3,4-f)indoltrihydrochlorid.

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: JK THORSENS PATENTBUREAU AS, POSTBOKS 9276 GRONLAN

MK1K Patent expired